- Home
- EBON vs GDTC Comparison
EBON vs GDTC Comparison
Compare EBON & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- GDTC
- Stock Information
- Founded
- EBON 2010
- GDTC 2018
- Country
- EBON China
- GDTC Singapore
- Employees
- EBON N/A
- GDTC N/A
- Industry
- EBON Semiconductors
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- GDTC Health Care
- Exchange
- EBON Nasdaq
- GDTC Nasdaq
- Market Cap
- EBON 25.3M
- GDTC 28.0M
- IPO Year
- EBON 2020
- GDTC 2023
- Fundamental
- Price
- EBON $4.90
- GDTC $2.02
- Analyst Decision
- EBON
- GDTC Buy
- Analyst Count
- EBON 0
- GDTC 1
- Target Price
- EBON N/A
- GDTC $5.00
- AVG Volume (30 Days)
- EBON 34.4K
- GDTC 7.9K
- Earning Date
- EBON 08-22-2025
- GDTC 01-01-0001
- Dividend Yield
- EBON N/A
- GDTC N/A
- EPS Growth
- EBON N/A
- GDTC N/A
- EPS
- EBON N/A
- GDTC N/A
- Revenue
- EBON $5,868,771.00
- GDTC $368,838.00
- Revenue This Year
- EBON N/A
- GDTC $5.37
- Revenue Next Year
- EBON N/A
- GDTC N/A
- P/E Ratio
- EBON N/A
- GDTC N/A
- Revenue Growth
- EBON 20.88
- GDTC N/A
- 52 Week Low
- EBON $3.00
- GDTC $1.20
- 52 Week High
- EBON $10.94
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- EBON 70.64
- GDTC 39.37
- Support Level
- EBON $4.66
- GDTC $2.01
- Resistance Level
- EBON $5.40
- GDTC $2.22
- Average True Range (ATR)
- EBON 0.35
- GDTC 0.10
- MACD
- EBON 0.19
- GDTC -0.02
- Stochastic Oscillator
- EBON 77.59
- GDTC 2.94
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.